Congenic mapping of the diabetogenic locus Idd4 to a 5.2-cM region of chromosome 11 in NOD mice: Identification of two potential candidate subloci

Diabetes

Volumn 51, Issue 1, 2002, Pages 215-223

  Grattan, Marsha ^a   Mi, Qing Sheng ^b   Meagher, Craig ^a   Delovitch, Terry L ^a  

^a ROBARTS RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; BETA CHEMOKINE; NITRIC OXIDE SYNTHASE;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHROMOSOME 11; CONGENIC STRAIN; CYTOKINE PRODUCTION; DISEASE RESISTANCE; FEMALE; GENE LOCUS; GENE MAPPING; HISTOPATHOLOGY; INCIDENCE; INSULITIS; LYMPHOCYTE PROLIFERATION; MOUSE; MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0036097734     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.51.1.215     Document Type: Article

References (44)

1. The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD
2. The NOD mouse: Recessive diabetogenic gene in the major histocompatibility complex
3. Three recessive loci required for insulin-dependent diabetes in nonobese diabetic mice
4. Genetics of autoimmune diabetes in animal models
5. Mapping autoimmunity genes
6. The NOD Idd9 genetic interval influences the pathogenicity of insulitis and contains molecular variants of Cd30, Tnfr2, and Cd137
7. Resistance alleles at two non-major histocompatibility complex-linked insulin-dependent diabetes loci on chromosome 3, Idd3 and Idd 10, protect nonobese diabetic mice from diabetes
8. Defective thymic T cell activation by concanavalin A and anti-CD3 in autoimmune nonobese diabetic mice: Evidence for thymic T cell anergy that correlates with the onset of insulitis
9. Thymic T cell anergy in autoimmune nonobese diabetic mice is mediated by deficient T cell receptor regulation of the pathway of p21ras activation
10. Altered thymic and peripheral T-lymphocyte repertoire preceding onset of diabetes in NOD mice
11. Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice
12. Genetic linkage of thymic T-cell proliferative unresponsiveness to mouse chromosome 11 in NOD mice: A possible role for chemokine genes
13. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function
14. Islet-infiltrating lymphocytes from prediabetic NOD mice rapidly transfer diabetes to NOD-scid/scid mice
15. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Idd 10, localizes two genes mediating the Idd10 effect and eliminates the candidate Fcgrl
16. NOD Idd5 locus controls insulitis and diabetes and overlaps the orthologous CTLA4/IDDM 12 and NRAMP1 loci in humans
17. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism
18. Platelet-activating factor acetylhydrolases in health and disease
19. Platelet-activating factor and related lipid mediators
20. Elevated levels of paf-acether in blood of patients with type 1 diabetes mellitus
21. Increased blood levels of platelet-activating factor in insulin-dependent diabetic patients with microalbuminuria
22. Altered platelet activating factor metabolism in insulin dependent diabetes mellitus
23. Effects of ginkgolide B, a platelet-activating factor inhibitor on insulitis in the spontaneously diabetic BB rat
24. Protection from BB rat diabetes by the platelet-activating factor inhibitor BN50730
25. Recombinant human platelet-activating factor acetylhydrolase reduces the frequency of diabetes in the diabetesprone BB rat
26. Nitric oxide: A pathogenetic factor in autoimmunity
27. Type 1 (insulin-dependent) diabetes rellitus and nitric oxide
28. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis
29. Transgenic mice overexpressing type 2 nitric-oxide synthase in pancreatic beta cells develop insulin-dependent diabetes without insulitis
30. Chemokines: Chemotactic cytokines that mediate inflammation
31. RelB regulation of chemokine expression modulates local inflammation
32. Chemokines and T lymphocytes: More than an attraction
33. MIP-1α and MCP-1 differentially regulate acute and relapsing autoimmune encephalomyelitis as well as Th1/Th2 lymphocyte differentiation
34. An important role for the chemokine macrophage inflammatory protein-1α in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis
35. Chemokine regulation of experimental autoimmune encephalomyelitis: Temporal and spatial expression patterns govern disease pathogenesis
36. Th1- and Th2-type cytokines regulate chemokine expression
37. Islet-specific Th1, but not Th2, cells secrete multiple chemokines and promote rapid induction of autoimmune diabetes
38. Differential expression of CCchemokines and the CCR5 receptor in the pancreas is associated with progres sion to type I diabetes
39. The biology of chemokines and their receptors
40. Clustering of cytokine genes on mouse chromosome 11
41. New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice
42. Lupus susceptibility loci in New Zealand mice
43. NIDDM genes in mice: Deleterious synergism by both parental genomes contributes to diabetogenic thresholds
44. QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15-cM region containing 112